SCGB2A2 and neoplasm: In breast cancer mammaglobin A is overexpressed in a high proportion of primary tumors [7,14-17], and it is associated with estrogen receptor positive tumors, a less aggressive tumor phenotype [7,14,15,17], and relapse-free survival [7].